Atlas Trials

Repurposed Therapeutics, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Repurposed Therapeutics, Inc.

RecordFirmDate
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion (NCT05548270)Repurposed Therapeutics, Inc.2022-08-23
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance (NCT05886660)Repurposed Therapeutics, Inc.2022-01-21
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance (NCT05852730)Repurposed Therapeutics, Inc.2021-08-10
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion (NCT04947423)Repurposed Therapeutics, Inc.2021-06-14
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness (NCT04184115)Repurposed Therapeutics, Inc.2019-06-09
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects (NCT03988530)Repurposed Therapeutics, Inc.2019-06-07
The Prevention and Treatment of Nausea Associated With Motion Sickness (NCT03986905)Repurposed Therapeutics, Inc.2019-04-26
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness (NCT04272255)Repurposed Therapeutics, Inc.2019-04-22
Scopolamine in Healthy Volunteers (NCT03874130)Repurposed Therapeutics, Inc.2018-08-01
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness (NCT04219982)Repurposed Therapeutics, Inc.2018-06-29

Track Repurposed Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.